Viewing nowCombinationOkmaril M Tablets 2 / 500 milligrams
Metformin Hydrochloride 500mg · Glimepiride 2mg
Tablet · Prescription medication · Combination
Os Korea Pharmaceutical Co., Ltd.

MFDS item code 201604018 · Approved 2016.06.28 · Insurance code 629701010
Improvement of glycemic control in type 2 diabetes mellitus
This medication helps assist dietary and exercise management for patients with type 2 diabetes to control their blood sugar. Glimepiride and metformin work together to efficiently lower blood sugar levels. Therefore, this medication is used for patients with type 2 diabetes who require blood sugar control.
This medicine is administered 1~2 times daily immediately before or with a meal. The dose may be adjusted according to each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted according to the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and experience is available with gradual dose increases based on blood glucose monitoring up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional effect at doses above 4mg daily, although some patients have shown better metabolic control with doses increased to 6mg (or 8mg). When used as an alternative to combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being used in combination. Do not take more than a single dose at the next scheduled administration, even if a previous dose was missed.
This medication may cause severe lactic acidosis or hypoglycemia, so treatment should be temporarily suspended, and the physician consulted if there is a rapid decline in kidney function or signs of dehydration. This medication should not be administered to patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver or kidney function impairment, pregnant women, and breastfeeding women. Patients at high risk of hypoglycemia, such as the elderly, those in a malnourished state, with irregular eating habits, or engaging in vigorous physical exercise, should be monitored closely during administration. Initial treatment may lead to gastrointestinal symptoms (diarrhea, nausea, vomiting), but these are usually temporary and can be alleviated by taking the medication with food or gradually increasing the dosage. This medication may interact with other medications that have blood sugar-lowering effects, so if you are taking other drugs, be sure to inform your doctor or pharmacist. Women who are pregnant or planning to become pregnant should not take this medication and should use other methods, such as insulin therapy, to control their blood sugar. Elderly patients often experience diminished kidney function; therefore, regular kidney function tests should be conducted before and during treatment with this medication, and dosage may need to be adjusted according to kidney function. If unexplained muscle pain, weakness, difficulty breathing, abdominal pain, or altered consciousness occurs during treatment, discontinue use immediately and inform a physician, as these could be signs of lactic acidosis. Overdose may lead to hypoglycemia; if symptoms appear, immediately consume sugar and seek medical assistance. This medication may decrease vitamin B12 levels, so regular blood tests to monitor vitamin B12 levels are recommended for those on long-term treatment. When driving or operating machinery, caution is advised due to the risk of hypoglycemia or impaired agility. The safety for children and adolescents has not been adequately established, so special care is needed when administering this medication to minors. This medication should be kept out of reach of children and should not be transferred to other containers to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is best kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's efficacy over a longer period.
White oblong film-coated tablets
30 tablets per bottle, 300 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 500mg · Glimepiride 2mg
Tablet · Prescription medication · Combination
Os Korea Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Glimepiride 1mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Glimepiride 2mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Glimepiride 2mg
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
CombinationGlimepiride 2mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Hawon Pharmaceutical Co., Ltd.
Metformin Hydrochloride 500mg · Glimepiride 2mg
Tablet · Prescription medication · Combination
TDS Pharm Co., Ltd.
CombinationGlimepiride 2mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Il Yang Pharmaceutical Co., Ltd.
CombinationGlimepiride 2mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.